Please try another search
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing targeted radiotherapies to deliver cancer-killing radiation with cellular level precision to treat patients with high unmet needs. The Company develops and markets medicines for relapsed or refractory cancer patients who are treated primarily in large quaternary care hospitals and their catchment areas. Its Iomab-B and Actimab-A product candidates fill the major unmet medical needs in relapsed or refractory acute myeloid leukemia (r/r AML). Iomab-B is a targeted bridging therapy that provides both disease control and conditioning in one agent. Actimab-A is a targeted therapy for fit patients that has demonstrated an impressive extension in survival in a proof-of-concept study and is poised for advanced development in collaboration with the National Cancer Institute (NCI).
Name | Age | Since | Title |
---|---|---|---|
Hillard M. Lazarus | - | 2014 | Member of Scientific Advisory Board |
Sergio Giralt | - | 2014 | Member of Scientific Advisory Board |
Richard M. Stone | - | 2017 | Member of Scientific Advisory Board |
Richard Wahl | - | - | Member of Clinical Advisory Board |
Jeffrey W. Chell | 67 | 2018 | Independent Director |
Richard I. Steinhart | 64 | 2013 | Independent Director |
M. Yair Levy | - | 2014 | Member of Scientific Advisory Board |
Ajit S. Shetty | 74 | 2017 | Independent Director |
Alexander Perl | - | - | Member of Clinical Advisory Board |
John M. Pagel | - | - | Chairman of Scientific Advisory Board & Member of Clinical Advisory Board |
David A. Scheinberg | 65 | - | Member of Clinical Advisory Board |
Sandesh C. Seth | 57 | 2012 | Chairman & CEO |
Joseph G. Jurcic | - | - | Chairman of Clinical Advisory Board |
Elihu H. Estey | - | - | Member of Clinical Advisory Board |
Franklin Wong | - | 2018 | Members of Nuclear Medicine Clinical Advisory Board |
Hagop M. Kantarjian | - | - | Member of Clinical Advisory Board |
Richard E. Champlin | - | 2014 | Member of Scientific Advisory Board |
Michael Yu | - | 2018 | Members of Nuclear Medicine Clinical Advisory Board |
Dan Pryma | - | 2018 | Members of Nuclear Medicine Clinical Advisory Board |
Johannes Czernin | - | 2018 | Members of Nuclear Medicine Clinical Advisory Board |
Ghassan El-Haddad | - | 2018 | Members of Nuclear Medicine Clinical Advisory Board |
David Colcher | - | 2018 | Members of Nuclear Medicine Clinical Advisory Board |
C. David Nicholson | 66 | 2008 | Lead Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review